Clinical Trials

Registry push could ease patients' hunt for drug

Published in Physician Law Weekly, October 20th, 2004

Scientists are conducting thousands of medical experiments that can offer tantalizing hope to the ill, but tracking them down and getting enrolled can be incredibly difficult.

It might get easier, thanks to a growing push by doctors and lawmakers to force drug companies to list on a national registry every study they conduct.

Currently, learning what experimental treatments are being tested for diseases ranging from arthritis to cancer to Parkinson's is a hit-or-miss proposition. It's one reason so few patients participate; even for cancer, where clinical trials are touted most, just 3% to 5% of patients are estimated to enroll.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2004-10-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry